​

Inhibrx Biosciences (INBX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Inhibrx Biosciences Revenue Highlights

Latest Revenue (Y)

$1.30M

0

Main Segment (Y)

License, Non-Affiliate

Inhibrx Biosciences Revenue by Period

Inhibrx Biosciences Revenue by Year

DateRevenueChange
2025-12-31$1.30M550.00%
2024-12-31$200.00K-88.89%
2023-12-31$1.80M-17.88%
2022-12-31$2.19M-69.24%
2021-12-31$7.13M-44.37%
2020-12-31$12.81M40.86%
2019-12-31$9.09M21.24%
2018-12-31$7.50M-5.66%
2017-12-31$7.95M19.24%
2016-12-31$6.67M-

Inhibrx Biosciences generated $1.30M in revenue during NA 2025, up 550.00% compared to the previous quarter, and up 10.15% compared to the same period a year ago.

Inhibrx Biosciences Revenue by Quarter

DateRevenueChange
2026-03-31-100.00%
2025-12-31-100.00%
2025-09-30--100.00%
2025-06-30$1.30M100.00%
2025-03-31--100.00%
2024-12-31$100.00K100.00%
2024-09-30--100.00%
2024-06-30$100.00K100.00%
2024-03-31--100.00%
2023-12-31$1.63M1273.11%
2023-09-30$119.00K296.67%
2023-06-30$30.00K76.47%
2023-03-31$17.00K-93.80%
2022-12-31$274.00K-1.44%
2022-09-30$278.00K-60.90%
2022-06-30$711.00K-22.30%
2022-03-31$915.00K-67.74%
2021-12-31$2.84M13.08%
2021-09-30$2.51M173.20%
2021-06-30$918.00K6.37%
2021-03-31$863.00K-68.91%
2020-12-31$2.78M-52.35%
2020-09-30$5.83M74.75%
2020-06-30$3.33M282.34%
2020-03-31$872.00K226.59%
2019-12-31$267.00K-66.37%
2019-09-30$794.00K-20.60%
2019-06-30$1.00M-85.78%
2019-03-31$7.03M209.92%
2018-12-31$2.27M-9.24%
2018-06-30$2.50M-
2018-03-31$2.50M789.68%
2017-12-31$281.00K-

Inhibrx Biosciences generated - in revenue during Q1 2026, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Inhibrx Biosciences Revenue Breakdown

Inhibrx Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22Dec 21
License, Non-Affiliate$1.30M$200.00K$1.80M$2.18M-
Grant---$14.00K$86.00K
License---$2.18M-

Inhibrx Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 25: License, Non-Affiliate (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Dec 24Jun 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
License, Non-Affiliate-$1.30M$1.30M$100.00K$100.00K$1.75M$30.00K$17.00K$278.00K$711.00K$915.00K$2.51M$918.00K$863.00K$3.83M---
Grant-----------$14.00K$20.00K$24.00K$36.00K$26.00K$300.00K-
License--------$274.00K$2.84M--------
License, Affiliate-----------------$2.00M
License, Affiliate - PD-L1 And 4-1BB License Agreement------------------
License, Affiliate - OX40 License Agreement-----------------$2.00M

Inhibrx Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SNDXSyndax Pharmaceuticals$172.35M$64.86M
NKTRNektar Therapeutics$55.23M$10.86M
IMTXImmatics$54.00M$30.45M
CVACCureVac$52.70M$12.37M
RLAYRelay Therapeutics$15.36M$3.00M
INBXInhibrx Biosciences$1.30M-
ATAIAtai Beckley-$749.00K
ELVNEnliven Therapeutics--
SANASana Bio--
AMLXAmylyx Pharmaceuticals--
ORICORIC Pharmaceuticals--

INBX Revenue FAQ

What is Inhibrx Biosciences’s yearly revenue?

Inhibrx Biosciences's yearly revenue for 2025 was $1.3M, representing an increase of 550.00% compared to 2024. The company's yearly revenue for 2024 was $200K, representing a decrease of -88.89% compared to 2023. INBX's yearly revenue for 2023 was $1.8M, representing a decrease of -17.88% compared to 2022.

What is Inhibrx Biosciences’s quarterly revenue?

Inhibrx Biosciences's quarterly revenue for Q1 2026 was $0, a 100.00% increase from the previous quarter (Q4 2025), and a 0% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $0, a 100.00% increase from the previous quarter (Q3 2025), and a -100.00% decrease year-over-year (Q4 2024). INBX's quarterly revenue for Q3 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024).

What is Inhibrx Biosciences’s revenue growth rate?

Inhibrx Biosciences's revenue growth rate for the last 3 years (2023-2025) was -27.78%, and for the last 5 years (2021-2025) was -81.75%.

What are Inhibrx Biosciences’s revenue streams?

Inhibrx Biosciences's revenue streams in c 25 are License, Non-Affiliate

What is Inhibrx Biosciences’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Inhibrx Biosciences was License, Non-Affiliate. This segment made a revenue of $1.3M, representing 100.00% of the company's total revenue.